Home > Injecting risk practices and Hepatitis C.

Butler, Kerryn and Burns, Lucinda [NDARC] . (2015) Injecting risk practices and Hepatitis C. Sydney: National Drug and Alcohol Research Centre. 4 p.

[img]
Preview
PDF (Injecting risk practices and Hepatitis C)
825kB

Key findings
• Sharing needles/syringes and injecting equipment poses a substantial risk to HCV transmission among PWID.
• While needle/syringe sharing is low among PWID, equipment sharing is far more common.
• Those who have tested positive to HCV antibodies are 7.5 times more likely to receptively share needles/syringes than those who tested negative to HCV antibodies, thereby putting themselves at increased risk.
• Harm minimisation interventions and public health messages need to target this behaviour to reduce the risk of HCV infection.


Item Type:Evidence resource
Publication Type:Report
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Source:NDARC
Date:2015
Pages:4 p.
Publisher:National Drug and Alcohol Research Centre
Place of Publication:Sydney
EndNote:View
Subjects:G Health and disease > Disorder by cause > Communicable disease > Hepatitis C
J Health care, prevention and rehabilitation > Risk and protective factors > Risk factors
J Health care, prevention and rehabilitation > Substance use prevention > Substance use harm reduction
T Demographic characteristics > Intravenous / injecting drug user
VA Geographic area > Australia and Oceania > Australia

Repository Staff Only: item control page